ADVANCED HEALTH LIMITED

(Incorporated in the Republic of South Africa)

(Registration number 2013/059246/06) ("the Company" or "Advanced Health")

ISIN Code: ZAE000189049

JSE Code: AVL

TRADING STATEMENT

In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required to publish a trading statement as soon as they become reasonably certain that the financial results for the next period to be reported on will differ by more than 20% from those of the previous corresponding period.

The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated results for the six months ended 31 December 2021, the Company expects a 3.1% improvement in a loss per of 2.81 cents compared to a loss per share of 2.90 cent in the comparative period.

The headline loss per share for the six months ended 31 December 2021 is expected to be 2.81 cents compared to a headline loss per share of 2.16 cent in the comparative period, a 30.1% increase in headline loss per share.

The information in this trading statement has not been reviewed and reported on by the Company's auditors.

Pretoria.

24 February 2022

Designated Advisor

Grindrod Bank Limited

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Advanced Health Limited published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 13:25:05 UTC.